Page last updated: 2024-10-18

dalteparin and Apnea, Obstructive Sleep

dalteparin has been researched along with Apnea, Obstructive Sleep in 1 studies

Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)

Research Excerpts

ExcerptRelevanceReference
"Acute pulmonary embolism (PE) may result in an increase in central venous pressure, which may contribute to pharyngeal narrowing by fluid accumulation in nuchal and peripharyngeal soft tissues and therefore affect obstructive sleep apnoea (OSA)."1.38Acute pulmonary embolism in patients with obstructive sleep apnoea: does it affect the severity of sleep-disordered breathing? ( Berghaus, TM; Faul, C; Schwaiblmair, M; Thilo, C; Unterer, F; von Scheidt, W, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berghaus, TM1
Faul, C1
Unterer, F1
Thilo, C1
von Scheidt, W1
Schwaiblmair, M1

Other Studies

1 other study available for dalteparin and Apnea, Obstructive Sleep

ArticleYear
Acute pulmonary embolism in patients with obstructive sleep apnoea: does it affect the severity of sleep-disordered breathing?
    Sleep & breathing = Schlaf & Atmung, 2012, Volume: 16, Issue:4

    Topics: Acute Disease; Aged; Airway Resistance; Anticoagulants; Central Venous Pressure; Enoxaparin; Female;

2012